WO2004048518A3 - Proteines associees aux organites - Google Patents

Proteines associees aux organites Download PDF

Info

Publication number
WO2004048518A3
WO2004048518A3 PCT/US2003/037278 US0337278W WO2004048518A3 WO 2004048518 A3 WO2004048518 A3 WO 2004048518A3 US 0337278 W US0337278 W US 0337278W WO 2004048518 A3 WO2004048518 A3 WO 2004048518A3
Authority
WO
WIPO (PCT)
Prior art keywords
orga
organelle
associated proteins
polynucleotides
agonists
Prior art date
Application number
PCT/US2003/037278
Other languages
English (en)
Other versions
WO2004048518A2 (fr
Inventor
Brooke M Emerling
David Chien
Jonathan T Wang
Thomas W Richardson
Jayalaxmi Ramkumar
Reena Khare
Vicki S Elliott
Soo Yeun Lee
Umesh G Bhatia
John D Burrill
Sally Lee
Julie J Blake
Anne Ho
Wenjin Zheng
Original Assignee
Incyte Corp
Brooke M Emerling
David Chien
Jonathan T Wang
Thomas W Richardson
Jayalaxmi Ramkumar
Reena Khare
Vicki S Elliott
Soo Yeun Lee
Umesh G Bhatia
John D Burrill
Sally Lee
Julie J Blake
Anne Ho
Wenjin Zheng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Brooke M Emerling, David Chien, Jonathan T Wang, Thomas W Richardson, Jayalaxmi Ramkumar, Reena Khare, Vicki S Elliott, Soo Yeun Lee, Umesh G Bhatia, John D Burrill, Sally Lee, Julie J Blake, Anne Ho, Wenjin Zheng filed Critical Incyte Corp
Priority to AU2003295760A priority Critical patent/AU2003295760A1/en
Publication of WO2004048518A2 publication Critical patent/WO2004048518A2/fr
Publication of WO2004048518A3 publication Critical patent/WO2004048518A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Dans divers modes de réalisation, l'invention concerne des protéines associées aux organites humains (ORGA) et des polynucléotides qui identifient et codent les ORGA. Dans des modes de réalisation, l'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Dans d'autres modes de réalisation, l'invention concerne des méthodes de diagnostic, de traitement ou de prévention de troubles associés à l'expression aberrante d'ORGA.
PCT/US2003/037278 2002-11-26 2003-11-21 Proteines associees aux organites WO2004048518A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003295760A AU2003295760A1 (en) 2002-11-26 2003-11-21 Organelle-associated proteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42944502P 2002-11-26 2002-11-26
US60/429,445 2002-11-26
US43083302P 2002-12-03 2002-12-03
US60/430,833 2002-12-03

Publications (2)

Publication Number Publication Date
WO2004048518A2 WO2004048518A2 (fr) 2004-06-10
WO2004048518A3 true WO2004048518A3 (fr) 2004-11-25

Family

ID=32397200

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/037278 WO2004048518A2 (fr) 2002-11-26 2003-11-21 Proteines associees aux organites

Country Status (2)

Country Link
AU (1) AU2003295760A1 (fr)
WO (1) WO2004048518A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1838872A2 (fr) * 2004-12-15 2007-10-03 Government of the United States of America as represented by The Secretary of the Department of Health and Human Services Marqueurs spanx-n specifiques du cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020091244A1 (en) * 1997-12-31 2002-07-11 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020091244A1 (en) * 1997-12-31 2002-07-11 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins

Also Published As

Publication number Publication date
WO2004048518A2 (fr) 2004-06-10
AU2003295760A8 (en) 2004-06-18
AU2003295760A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
WO2003052075A3 (fr) Enzymes
WO2002063005A3 (fr) Molecules associees a des lipides
WO2003042357A3 (fr) Enzymes
WO2002097060A3 (fr) Proteines associees aux carbohydrates
WO2004044165A3 (fr) Proteines associees aux lipides
WO2004053068A3 (fr) Molecules de modification et de maintenance de proteines
WO2003063688A3 (fr) Molecules de modification et d'entretien de proteines
WO2004009797A3 (fr) Molecules de modification et d'entretien de proteines
WO2003068943A3 (fr) Proteines secretees
WO2003062391A3 (fr) Proteines structurelle associees au cytosquelette
WO2003076586A3 (fr) Proteines associees a des acides nucleiques
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2004003162A3 (fr) Enzymes
WO2003087300A3 (fr) Proteines secretees
WO2003063769A3 (fr) Proteines associees aux vesicules
WO2003072729A3 (fr) Enzymes
WO2003100016A3 (fr) Molecules de modification et de maintenance de proteines
WO2003083082A3 (fr) Enzymes
WO2003093439A3 (fr) Enzymes
WO2003083084A3 (fr) Molecules de modification et d'entretien de proteines
WO2004022705A3 (fr) Proteines associees a la neurotransmission
WO2004094589A3 (fr) Proteines secretees
WO2004007527A3 (fr) Proteines secretees
WO2004111202A3 (fr) Proteines associees a la neurotransmission
WO2002083873A3 (fr) Enzymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP